Skip to main content
SpringerLink
Log in

Acute illness superimposed on chronic renal failure

  • Chapter
Critical Care Nephrology

  • 38 Accesses

Abstract

Acute renal failure (ARF) can be defined as a clinical syndrome characterized by a precipitous deterioration in renal function over a period of hours or days. In patients with the most severe ARF, dialysis will be required. The evolution is different from what is defined as chronic renal failure (CRF), where the decline in renal function takes place over several months to years. Despite the fact that ARF carries a high morbidity and mortality, the potential reversibilty of many entities of ARF mandates a rapid diagnosis and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P, and the French Study Group on Acute Renal Failure. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. Nephrol Dial Transpl 1996; 11: 293–9.

    Article  CAS  Google Scholar 

  2. Rasmussen HH, Pitt EA, Ibels LS, McNeil DR. Prediction of outcome in acute renal failure by discriminant analysis of clinical variables. Arch Intern Med 1985; 145: 2015–8.

    Article  PubMed  CAS  Google Scholar 

  3. Lohr JW, McFarlane MJ, Grantham JJ. A clinical index to predict survival in acute renal failure patients requiring dialysis. Am J Kidney Dis 1988; 11: 254–9.

    PubMed  CAS  Google Scholar 

  4. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983; 74: 243–8.

    Article  PubMed  CAS  Google Scholar 

  5. Spurney RF, Fulkerson WJ, Schwab SJ. Acute renal failure in critically ill patients: prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med 1991; 19: 8–11.

    Article  PubMed  CAS  Google Scholar 

  6. Cioffi WG, Ashikaga T, Gamelli RL. Probability of surviving postoperative acute renal failure. Ann Surg 1984; 200: 205–11.

    Article  PubMed  CAS  Google Scholar 

  7. Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988; 148: 1553–7.

    Article  PubMed  CAS  Google Scholar 

  8. Corwin HL, Teplick RS, Schreiber MJ, Fang LST, Bonventre JV, Coggins CH. Prediction of outcome in acute renal failure. Am J Nephrol 1987; 7: 8–12.

    Article  PubMed  CAS  Google Scholar 

  9. Schaefer J-H, Jochimsen F, Keller F, Wegscheider K, Distler A. Outcome prediction of acute renal failure in medical intensive care. Intensive Care Med 1991; 17: 19–24.

    Article  PubMed  CAS  Google Scholar 

  10. Cosentino F, Chaff C, Piedmonte M. Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant 1994; 9 (suppl 4): 179–82.

    PubMed  Google Scholar 

  11. Barton IK, Hilton PI, Taub NA, et al. Acute renal failure treated by haemofiltration: factors affecting outcome. Q J Med 1993; 86: 81–90.

    PubMed  CAS  Google Scholar 

  12. Lange HW, Aeppli DM, Brown DC. Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators. Am Heart J 1987; 113: 1138–43.

    Article  PubMed  CAS  Google Scholar 

  13. Groeneveld ABJ, Tran DD, Van der Meulen J, Nauta JJP, Thijs LG. Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. Nephron 1991; 59: 602–10.

    Article  PubMed  CAS  Google Scholar 

  14. Tran DD, Visser JJ. Possible protective effect of chronic renal failure against sepsis and endotoxininduced organ failure and mortality in acute renal failure. Nephron 1995; 69: 172–3.

    Article  PubMed  CAS  Google Scholar 

  15. Vijaykumar E, Raziuddin S, Wardle EN. Acute renal failure in the intensive care unit. Nephron 1992; 62: 473.

    Article  PubMed  CAS  Google Scholar 

  16. Packham DK, Hewitson TD, Yan HD, Elliott CE, Nicholls K, Becker GJ. Acute renal failure in IgA nephropathy. Clin Nephrol 1994; 42: 349–53.

    PubMed  CAS  Google Scholar 

  17. Jennette JC, Falk RJ. The diagnosis and management of glomerulonephritis and vasculitis presenting as acute renal failure. Med Clin North Am 1990; 74: 893–908

    PubMed  CAS  Google Scholar 

  18. Mason PD, Pusey CD. Glomerulonephritis: diagnosis and treatment. BMJ 1994; 309: 1557–63 (Erratum, BMJ 1995; 310: 116).

    Article  PubMed  CAS  Google Scholar 

  19. Wedeen RP. Environmental renal disease: Lead, cadmium and balkan endemic nephropathy. Kidney Int 1991; 40 (suppl 34): S4–8.

    Google Scholar 

  20. Staessen JA, Lauwereys RR, Buchet J-P et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 1992; 327: 151–6.

    Article  PubMed  CAS  Google Scholar 

  21. Neilson EG; Pathogenesis and therapy of interstitial nephritis. Kidney Int 1989; 35: 1257–70.

    Article  PubMed  CAS  Google Scholar 

  22. Ten RM, Tones VE, Milliner DS et al. Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin Proc 1988; 63: 921–30.

    Article  PubMed  CAS  Google Scholar 

  23. Preston RA, Stemmer CL, Materson BJ, et al. Renal biopsy in patients 65 years of age or older. An analysis of the results of 334 biopsies. J Am Geriatr Soc 1990; 38: 669–74.

    PubMed  CAS  Google Scholar 

  24. Stickler GB, Kelalia PP, Burke EC, Segar WE. Primary interstitial nephritis with reflux. Am J Dis Child 1971; 122: 144.

    PubMed  CAS  Google Scholar 

  25. Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992; 20: 140–3.

    PubMed  CAS  Google Scholar 

  26. Parfrey PS, Bear JC, Morgan J, et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323: 1085–90.

    Article  PubMed  CAS  Google Scholar 

  27. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertension 1995; 13: 915–24.

    Article  CAS  Google Scholar 

  28. Yagoob M, McClelland P, Ahmad R. Delayed recovery of renal function in patients with acute renal failure due to accelerated hypertension. Postgrad Med J 1991; 67: 829–32.

    Article  Google Scholar 

  29. Ihle BU, Long P, Oats J. Early onset pre-eclampsia: recognition of underlying renal disease. Br Med J 1987; 294: 79–81.

    Article  CAS  Google Scholar 

  30. Lindheimer MD, Cunningham FG. Hypertension and pregnancy: impact of the working group report. Am J Kidney Dis 1993; 21: 29–36.

    PubMed  CAS  Google Scholar 

  31. Hou SH, Grossman SD, Madias NE. Pregnancy in women with renal disease and moderate renal insufficiency. Am J Med 1985; 78: 185–94.

    Article  PubMed  CAS  Google Scholar 

  32. Imbasciati E, Pardi G, Capetta P, et al. Pregnancy in women with chronic renal failure. Am J Nephrol 1986; 6: 193–8.

    Article  PubMed  CAS  Google Scholar 

  33. Jungers P, Forget D, Houillier P, Henry-Amar M, Grunfeld JP. Pregnancy in IgA nephropathy, reflux nephropathy and focal glomerular sclerosis. Am J Kidney Dis 1987; 9: 334–8.

    PubMed  CAS  Google Scholar 

  34. Abe S. Pregnancy in IgA nephropathy. Kidney Int 1991; 40: 1098–102.

    Article  PubMed  CAS  Google Scholar 

  35. Becker GJ, Ihle BU, Fairly KF, et al. Effect of pregnancy on moderate renal failure in reflux nephropathy. BMJ 1986; 229: 796–8.

    Article  Google Scholar 

  36. Mintz G, Rodriguez-Alvarez E. Systemic lupus erythematosus. Rheum Dis Clin North Am 1989; 15: 255–74.

    PubMed  CAS  Google Scholar 

  37. Kitzmiller JL, Brown ER, Phillippe M, et al. Diabetic nephropathy and perinatal outcome. Am J Obstet Gynec 1981; 141: 741.

    PubMed  CAS  Google Scholar 

  38. Lameire N, Mathys E, Vanholder R, et al. Causes and prognosis of acute renal failure in older patients. Nephrol Dial Transplant 1987; 2: 316–22.

    PubMed  CAS  Google Scholar 

  39. Lindeman RD. Overview: renal physiology and pathophysiology of aging. Am J Kidney Dis 1990; 16: 275–82.

    PubMed  CAS  Google Scholar 

  40. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1986; 80: 435–42.

    Article  PubMed  CAS  Google Scholar 

  41. Anderson S, Brenner BM. The aging kidney: structure, function, mechanisms, and therapeutic implications. J Am Geriatr Soc 1987; 35: 590–3.

    PubMed  CAS  Google Scholar 

  42. Lameire N, Verspeelt J, Vanholder R, Ringoir S. A review of the pathophysiology, causes and prognosis of acute renal failure in the elderly. Geriat Nephrol and Urol 1991; 1: 77–91.

    Article  Google Scholar 

  43. Pascual J, Liano F, Ortuno J. The elderly patient with acute renal failure. J Am Soc Nephrol 1995; 6: 144–53.

    PubMed  CAS  Google Scholar 

  44. Blum U, Bilmann P, Krause T, et al. Effect of local low-dose thrombolysis on clinical outcome in acute embolic renal artery occlusion. Radiology 1993; 189: 549–54.

    PubMed  CAS  Google Scholar 

  45. Thadani RI, Camargo CA, Xavier RJ et al. Atheroembolic renal failure after invasive procedures. Natural history based on 52 biopsy-proven cases. Medicine 1995; 74: 350–8.

    Article  Google Scholar 

  46. Colt HG, Begg RJ, Saporito JJ et al. Cholesterol emboli after cardiac catheterization. Eight cases and a review of the literature. Medicine 1988; 67: 389–400.

    Article  PubMed  CAS  Google Scholar 

  47. Mannesse CK, Blankestijn PJ, Man in ‘t Veld AJ, Schalekamp MA. Renal failure and cholesterol crystal embolization: a report of 4 surviving cases and a review of the literature. Clin Nephrol 1991; 36: 240–5.

    PubMed  CAS  Google Scholar 

  48. Meyrier A, Buchet P, Simon P, et al. Atheromatous renal disease. Am J Med 1988; 85: 139–46.

    Article  PubMed  CAS  Google Scholar 

  49. Hyman BT, Landas SK, Ashwan RF, et al. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987; 82: 1233–7.

    Article  PubMed  CAS  Google Scholar 

  50. Gupta BK, Spinowitz BS, Charytan C, Wahl SJ. Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator. Am J Kidney Dis 1993; 21: 659–62.

    PubMed  CAS  Google Scholar 

  51. Lessman RK, Johnson SR, Coburn JW, Kaufman JJ. Renal artery embolism: clinical features and long-term follow-up of 17 cases. Ann Intern Med 1978; 89: 477–82.

    PubMed  CAS  Google Scholar 

  52. Cosio FG, Zager RA, Sharma HM. Atheroembolic renal disease causes hypocomplementemia. Lancet 1985; 2: 118–21.

    Article  PubMed  CAS  Google Scholar 

  53. Kasinath BS, Lewis EJ. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch Intern Med 1987; 147: 1384–5.

    Article  PubMed  CAS  Google Scholar 

  54. Wilson DM, Salazar TL, Farkouh ME. Eosinophiluria in atheroembolic renal disease. Am J Med 1991; 91: 186–9.

    Article  PubMed  CAS  Google Scholar 

  55. Gall MA, Rossing P, Skott P, et al. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (noninsulin-dependent) diabetic patients. Diabetologia 1991; 34: 655–61.

    Article  PubMed  CAS  Google Scholar 

  56. Jarrett RJ. Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab Rev 1989; 5: 547–58.

    Article  PubMed  CAS  Google Scholar 

  57. Schiff HI. The neurogenic bladder in diabetes mellitus. N Y State J Med 1982; 82: 922.

    PubMed  CAS  Google Scholar 

  58. Frimondt-Moller C. Diabetic cystopathy. Dan Med Bull 1978; 25: 49.

    Google Scholar 

  59. Eknoyan G, Qunibi WY, Grissom RT, Tuma SN, Ayus JC. Renal papillary necrosis: an update. Medicine 1982; 61: 55.

    Article  PubMed  CAS  Google Scholar 

  60. Muirhead EE, Vanatta J, Grollman A. Papillary necrosis of the kidney: a clinical and experimental condition. JAMA 1950; 142: 627.

    Article  CAS  Google Scholar 

  61. Solez K, Ponchak S, Buono RA, et al. Inner medullary plasma flow in the kidney with ureteral obstruction. Am J Physiol 1976; 231: 1315–21.

    PubMed  CAS  Google Scholar 

  62. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995; 59: 962–8.

    Article  PubMed  CAS  Google Scholar 

  63. Halloran PF, Aprile MA, Farewell V, et al. Early function as the principle correlate of graft survival: A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988; 46: 223–8.

    Article  PubMed  CAS  Google Scholar 

  64. Feldman HI, Fazio I, Roth D, et al. Recipient body size and cadaveric renal allograft survival. J Am Soc Nephrol 1996; 7: 151–7.

    PubMed  CAS  Google Scholar 

  65. Sanders PW. Pathogenesis and treatment of myeloma kidney. J Lab Clin Med 1994; 124: 484–8.

    PubMed  CAS  Google Scholar 

  66. Defronzo RA, Humphrey RL, Wright JR, Cooke CR. Acute renal failure in multiple myeloma. Medicine 1975; 54: 209–223.

    Article  PubMed  CAS  Google Scholar 

  67. Cohen DJ, Sherman WH, Osserman EF, Appel GB. Acute renal failure in patients with multiple myeloma. Am J Med 1984; 76: 247–56.

    Article  PubMed  CAS  Google Scholar 

  68. Smolens P, Barnes JL, Kreisberg R. Hypercalcemia can potentiate the nephrotoxicity of Bence Jones proteins. J Lab Clin Med 1987; 110: 460–5.

    PubMed  CAS  Google Scholar 

  69. McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology 1992; 183: 519–21.

    PubMed  CAS  Google Scholar 

  70. Bohle A, Wehrmann M, Eissele R, von Gise H, Mackensen-Haen S, Müller C. The long-term prognosis of AA and AL renal amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis. Path Res Pract 1993; 189: 316–31.

    Article  PubMed  CAS  Google Scholar 

  71. Gertz AG, Kyle RA. Primary systemic amyloidosis-a diagnostic primer. Mayo Clin Proc 1989; 64: 1505–19.

    Article  PubMed  CAS  Google Scholar 

  72. Barton CH, Vaziri ND, Gordon S, Tilles S. Renal pathology in end-stage renal disease associated with paraplegia. Paraplegia 1984; 22: 31–41.

    Article  PubMed  CAS  Google Scholar 

  73. Rao TK, Filipone EJ, Nicastri AD, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 669–73.

    Article  PubMed  CAS  Google Scholar 

  74. Bourgoignie JJ. Renal complications of human immunodeficiency virus type 1. Kidney Int 1990; 37: 1571–84.

    Article  PubMed  CAS  Google Scholar 

  75. Rao TK. Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 1991; 35: S13–8.

    CAS  Google Scholar 

  76. Seney FD, Burns DK, Silva FG. Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 1990; 16: 1–13.

    PubMed  Google Scholar 

  77. Berns JS, Cohen RM, Stumacher RJ, Rudnick MR. Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections. J Am Soc Nephrol 1991; 1: 1061–80.

    PubMed  CAS  Google Scholar 

  78. Humphreys MH. Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 1995; 48: 311–20.

    Article  PubMed  CAS  Google Scholar 

  79. D’Agati V, Suh JI, Carbone L, et al. Pathology of HIV-associated nephropathy: a detailed morphologic and comparitive study. Kidney Int 1989; 35: 1358–70.

    Article  PubMed  Google Scholar 

  80. Cacoub P, Deray G, Baumelou A. Acute renal failure induced by foscarnet: 4 cases. Clin Nephrol 1988; 29: 315–8.

    PubMed  CAS  Google Scholar 

  81. Deray G, Martinez F, Katlama C et al. Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am J Nephrol 1989; 9: 316–21.

    Article  PubMed  CAS  Google Scholar 

  82. Sawyer MH, Webb DE, Balow JE, Straus SE. Acyclovir-induced renal failure. Clinical course and histology. Am J Med 1988; 84: 1067–71.

    Article  PubMed  CAS  Google Scholar 

  83. Studies of Ocular Complications of AIDS Research Group. Morbodity and toxic effects associated with ganciclovir or foscarnet treatment in a randomized cytomegalovirus retinitis trail. Arch Intern Med 1995; 155: 65–74.

    Article  Google Scholar 

  84. Krieble BF, Rudy DW, Glick MR, et al. Case report: acyclovir neurotoxicity and nephrotoxicity-a role for hemodialysis. Am J Med Sci 1993; 305: 36–9.

    Article  PubMed  CAS  Google Scholar 

  85. Bianchetti MG, Roduit C, Oetliker OH. Acyclovirinduced renal failure: course and risk factors. Pediatr Nephrol 1991; 5: 238–9.

    Article  PubMed  CAS  Google Scholar 

  86. Simon DI, Brosius FC III, Rothstein DM. Sulfadiazineinduced crystalluria revisited. The treatment of toxoplasma encephalitis in patients with acquired immune deficiency syndrome. Arch Intern Med 1990; 150: 2379–84.

    Article  PubMed  CAS  Google Scholar 

  87. Carbone LG, Bendixen B, Appel GB. Sulfadiazineassociated obstructive nephropathy occuring in a patient with the acquired immune deficiency syndrome. Am J Kidney Dis 1988; 12: 72–5.

    PubMed  CAS  Google Scholar 

  88. Lachaal M, Venuto RC. Nephrotoxicity and hyperkalemia in patients with acquired immune deficiency syndrome treated with pentamidine. Am J Med 1989; 87: 260–3.

    Article  PubMed  CAS  Google Scholar 

  89. Sattler FR, Cowen R, Neilsen DM, et al. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Ann Intern Med 1988; 109: 280–7.

    PubMed  CAS  Google Scholar 

  90. Cantor ES, Kimmel PL, Bosch JP. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 1991; 151: 125–8.

    Article  PubMed  CAS  Google Scholar 

  91. Miller RF, Delany S, Semple SGJ. Acute renal failure after nebulised pentamidine. Lancet 1989; 1: 1271–2.

    Article  PubMed  CAS  Google Scholar 

  92. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–62.

    Article  PubMed  CAS  Google Scholar 

  93. Textor SC, Novick AC, Tarazi RC, et al. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med 1985; 102: 308–14.

    PubMed  CAS  Google Scholar 

  94. Fommei E, Ghione S, Palla L. Renal scintigraphic captopril test in the diagnosis of renovascular hypertension. Hypertension 1987; 10: 212–20.

    Article  PubMed  CAS  Google Scholar 

  95. Donker AJM. Nephrotoxicity of angiotensin converting enzyme inhibition. Kidney Int 1987; 31: S132–7.

    Google Scholar 

  96. Chapman AB, Gabow PA, Schrier RW. Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med 1991; 115: 769–73.

    PubMed  CAS  Google Scholar 

  97. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renine-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323: 1091–6.

    Article  PubMed  CAS  Google Scholar 

  98. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984; 310: 563–72.

    Article  PubMed  CAS  Google Scholar 

  99. Stillman MT, Schleisinger PA. Nonsteroidal anti-inflammatory drug nephrotoxicity. Arch Intern Med 1990; 150: 268–70.

    Article  PubMed  CAS  Google Scholar 

  100. Unsworth J, Sturman S, Lunec J et al. Renal impairment associated with nonsteroidal anti-inflammatory drugs. J Rheum Dis 1987; 46: 233–6.

    Article  CAS  Google Scholar 

  101. Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 1987; 32: 1–12.

    Article  PubMed  CAS  Google Scholar 

  102. Carmichael J, Shankel SW. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 1985; 78: 992–1000.

    Article  PubMed  CAS  Google Scholar 

  103. Adams DH, Michael J, Baconn PA, et al. Nonsteroidal anti-inflammatory drugs and renal failure. Lancet 1986; 1: 57–9.

    Article  PubMed  CAS  Google Scholar 

  104. Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. Ann Intern Med 1990; 112: 559–60.

    PubMed  CAS  Google Scholar 

  105. Morgenstern SJ, Burns FJ, Fraley DS, et al. Ibuprofen-associated lipid nephrosis without interstitial nephritis. Am J Kidney Dis 1989; 16: 50–2.

    Google Scholar 

  106. Finkelstein A, Fraley DS, Stachura I, et al. Fenprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder. Am J Med 1982; 72: 81–7.

    Article  PubMed  CAS  Google Scholar 

  107. Katz S, Capaldo R, Everts E, et al. Association with reversible renal failure and acute interstitial nephritis. JAMA 1981; 246: 243–5.

    Article  PubMed  CAS  Google Scholar 

  108. Whelton A, Stout LS, Spilman PS, Klassen DK. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, cross-over comparison. Ann Intern Med 1990; 112: 568–76.

    PubMed  CAS  Google Scholar 

  109. Magil AB, Ballon HS, Cameron EC, Rae A. Acute interstitial nephritis associated with thiazide diuretics. Clinical and pathologic observations in three cases. Am J Med 1980; 69: 939–43.

    Article  PubMed  CAS  Google Scholar 

  110. Neumayer H-H, Färber L, Haller P et al. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Nephrol Dial Transplant 1996; 11: 165–72.

    Article  PubMed  CAS  Google Scholar 

  111. Bonser RS, Adu D, Franklin I et al. Cyclosporininduced haemolytic uraemic syndrome in liver allograft recipient. Lancet 1984; 2: 1337.

    Article  PubMed  CAS  Google Scholar 

  112. Shulman H, Striker G, Deeg HJ, et al. Nephrotoxicity of cyclosporin A after allogenic marrow transplantation: Glomerular thromboses and tubular injury. N Engl J Med 1981; 305: 1392–5.

    Article  PubMed  CAS  Google Scholar 

  113. Bennett WM, Pulliam JP: Cyclosporine nephrotoxicity. Ann Intern Med 1983; 99: 851–4.

    PubMed  CAS  Google Scholar 

  114. Textor SC, Wiesner R, Wilson DJ, et al. Systemic and renal hemodynamic differences between FK 506 and cyclosporine in liver transplant recipients. Transplantation 1993; 55: 1332–9.

    Article  PubMed  CAS  Google Scholar 

  115. Porayko MK, Textor SC, Krom RAF, et al. Nephrotoxic effects of primary immunosuppression with FK506 and cyclosporine regimens in liver transplantation. Mayo Clin Proc 1994; 69: 105–11.

    Article  PubMed  CAS  Google Scholar 

  116. Randhawa PS, Shapiro R, Jordan ML, et al. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Am J Surg Pathol 1993; 17: 60–8.

    Article  PubMed  CAS  Google Scholar 

  117. Idee JM, Beaufils H, Bonnemain B. Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention. Fundam Clin Pharmacol 1994; 8: 193–206.

    Article  PubMed  CAS  Google Scholar 

  118. Parfrey PS, Griffiths SM, Barret BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320: 143–9.

    Article  PubMed  CAS  Google Scholar 

  119. Rudnick MR, Goldfarb S, Weeler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trail. Kidney Int 1995; 47: 254–6.

    Article  PubMed  CAS  Google Scholar 

  120. Harris KG, Smith TP, Cragg AH, Lemke JH. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. Radiology 1991; 179: 849–52.

    PubMed  CAS  Google Scholar 

  121. Cronin RE. Renal failure following radiologic procedures. Am J Med Sci 1989; 296: 342–56.

    Article  Google Scholar 

  122. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterisation in patients 70 years of age or older. A prospective study. Arch Intern Med 1990; 150: 1237–42.

    Article  PubMed  CAS  Google Scholar 

  123. Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. Am J Radiol 1991; 157: 49–58.

    CAS  Google Scholar 

  124. Barret BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high-and low-osmolality ionidated contrast media. Radiology 1993; 188: 171–8.

    Google Scholar 

  125. Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416–20.

    Article  PubMed  CAS  Google Scholar 

  126. Leehy DJ, Braun BI, Tholl Da, et al. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy? J Am Soc Nephrol 1993; 4: 81–90.

    Google Scholar 

  127. Luft FC. Clinical significance of renal changes engendered by aminoglycosides in man. J Antimicrob Chemother 1984; 13 (suppl A): 23–30.

    Article  PubMed  CAS  Google Scholar 

  128. Humes HD. Aminoglycoside nephrotoxicity. Kidney Int 1988; 33: 900–11.

    Article  PubMed  CAS  Google Scholar 

  129. Goetze MB, Sayers J. Nephrotoxicity of vancomycin and aminoglycoside therapy separatly and in combination. J Antimicrob Chemother 1993; 32: 325–34.

    Article  Google Scholar 

  130. Prins JM, Buller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamycin in patients with serious infections. Lancet 1993; 341: 335–9.

    Article  PubMed  CAS  Google Scholar 

  131. EORTC International Antimicrobial Therapy Project Group. Efficacy and toxicity of single daily dose of amikacin and ceftriaxone versus multiple doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993; 119: 584–93.

    Google Scholar 

  132. Rybak MJ, Albrecht LM, Boike SC, Chandrasekan PH. Nephrotoxicity of Vancomycin alone and with an aminoglycoside. J Antimicrob Chemother 1990; 25: 679–87.

    Article  PubMed  CAS  Google Scholar 

  133. Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984; 100: 352–7.

    PubMed  CAS  Google Scholar 

  134. Desai T, Tsang T. Aminoglycoside nephrotoxicity in obstructive jaundice. Am J Med 1988; 85: 47–50.

    Article  PubMed  CAS  Google Scholar 

  135. Farber BF, Moellering FC. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983; 23: 138–41

    Google Scholar 

  136. Downs NJ, Neihart RE, Dolezal JM, et al. Mild nephrotoxicity associated with vancomycin use. Arch Intern Med 1989; 149: 1777–81.

    Article  PubMed  CAS  Google Scholar 

  137. Appel GB, Given DB, Levin LR, Cooper GL. Vancomycin and the kidney. Am J Kidney Dis 1986; 8: 75–80.

    PubMed  CAS  Google Scholar 

  138. Fisher MA, Talbot GH, Maislin G, McKeon BP, Tynan KP, Strom BL. Risk factors for amphotericin B-associated nephrotoxicity. Am J Med 1989; 87: 547–52.

    Article  PubMed  CAS  Google Scholar 

  139. Cheng JT, Witty RT, Robinson RR, et al. Amphotericin B nephrotoxicity: increased renal resistance and tubular permeability. Kidney Int 1982; 22: 626–33.

    Article  PubMed  CAS  Google Scholar 

  140. Schmitt HJ. New methods of delivery of amphotericin B. Clin Infect Dis 1993; 17 (suppl 2): S501–6.

    Article  PubMed  Google Scholar 

  141. Janknegt R, de Marie S, Bakker-Woudenberg IA, Crommelin DJA. Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet 1992; 23: 279–91.

    Article  PubMed  CAS  Google Scholar 

  142. de Marie S, Janknegt R, Bakker-Woudenberg IA. Clinical use of liposomal and lipid-complexed amphotericin B. J Antimicrob Chemother 1994; 33: 907–16.

    Article  PubMed  Google Scholar 

  143. Craswell PW, Price J, Boyle PD, et al. Chronic renal failure with gout: a marker of chronic lead poisining. Kidney Int 1979; 26: 169–73.

    Google Scholar 

  144. Jarup L, Persson B, Edling C, Elinder CG. Renal function impairment in workers previously exposed to cadmium. Nephron 1993; 64: 75–81.

    Article  PubMed  CAS  Google Scholar 

  145. Gernstner HB, Huff JE. Selected case histories and epidemiologic examples and human mercury poisoning. Clin Toxicol 1977; 11: 131–50.

    Article  Google Scholar 

  146. Agocs MM, Etzel RA, Gibson Parrish R, et al. Mercury exposure from interior latex paint. N Engl J Med 1990; 323: 1096–100.

    Article  PubMed  CAS  Google Scholar 

  147. Fowler BA, Weissberg JB. Arsine poisoning. N Engl J Med 1972; 291: 1171–4.

    Article  Google Scholar 

  148. Vogelzang NJ, Torkelson JL, Kennedy BJ. Hypomagnesemia, renal dysfunction and Raynaud’s phenomenon in patients treated with cisplatin, vinblastin and bleomycin. Cancer 1985; 56: 2765–70.

    Article  PubMed  CAS  Google Scholar 

  149. Hayes DM. High-dose cis-platinum diammine dichloride: Amelioration of renal toxicity by mannitol diuresis. Cancer 1977; 39: 1372–6.

    Article  PubMed  CAS  Google Scholar 

  150. Ozols RF, Corden BJ, Jacob J, et al. High dose cisplatin in hypertonic saline. Ann Intern Med 1984; 100: 19–24.

    PubMed  CAS  Google Scholar 

  151. Kosmidis PA, Samantas E, Fountzilas G, Pavlidis N, Apostolopoulou F, Skarlos D. Cisplatin/etopside versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III trail. Semin Oncol 1994; 21 (3 suppl 6): 23–30.

    PubMed  CAS  Google Scholar 

  152. Hricik DE, Goldsmith GH. Uric acid nephrolithiasis and acute renal failure secondary to streptozocin nephrotoxicity. Am J Med 1988; 84: 153–6.

    Article  PubMed  CAS  Google Scholar 

  153. Bleyer WA. The clinical pharmacology of methotrexate. Cancer 1978; 41: 36–51.

    Article  PubMed  CAS  Google Scholar 

  154. Vanholder R, Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review. J Am Soc Nephrol 1993; 3: 1541–54.

    CAS  Google Scholar 

Download references

Authors
  1. Eric Hoste
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norbert Lameire
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raymond Vanholder
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hoste, E., Lameire, N., Vanholder, R. (1998). Acute illness superimposed on chronic renal failure. In: Critical Care Nephrology. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5482-6_127

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5482-6_127

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6306-7

  • Online ISBN: 978-94-011-5482-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation